Study ID: BDB-AS-30039 | 2015-002510-80
Study Title
- Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Teva Identifier
- BDB-AS-30039 | 2015-002510-80
ClinicalTrials.gov Identifier
- NCT02513160
Study Status
- Completed
Trial Condition(s)
- Persistent Asthma
Interventions
- Drug: Beclomethasone Dipropionate 640 | Drug: Placebo | Drug: Beclomethasone dipropionate via 320 mcg BAI | Drug: albuterol/salbutamol | Drug: Beclomethasone dipropionate via 320 mcg MDI
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- September 30, 2015 - March 31, 2016
Phase
- Phase 3
Study Type
Interventional
